Literature DB >> 23225668

Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium.

Allison J Rao1, Christophe Nich, Lakshmi S Dhulipala, Emmanuel Gibon, Roberto Valladares, Stefan Zwingenberger, R Lane Smith, Stuart B Goodman.   

Abstract

Wear particles generated with use of total joint replacements incite a chronic macrophage-mediated inflammatory reaction, which leads to implant failure. Macrophage activation may be polarized into two states, with an M1 proinflammatory state dominating an alternatively activated M2 anti-inflammatory state. We hypothesized that IL-4, an activator of M2 macrophages, could modulate polyethylene (PE) particle-induced osteolysis in an experimental murine model. Four animal groups included (a) calvarial saline injection with harvest at 14 days (b) single calvarial injection of PE particles subcutaneously (SC) without IL-4 (c) PE particles placed as in (b), then IL-4 given SC for 14 consecutive days and (d) PE particles as in (b) then IL-4 beginning 7 days after particle injection for 7 days. The calvarial bone volume to total tissue volume was measured using microCT and histomorphometry. Calvaria were cultured for 24 h to assess release of RANKL, OPG, TNF-α, and IL-1ra and isolation and identification of M1 and M2 specific proteins. MicroCT and histomorphometric analysis showed that bone loss was significantly decreased following IL-4 administration to PE treated calvaria for both 7 and 14 days. Western blot analysis showed an increased M1/M2 ratio in the PE treated calvaria, which decreased with addition of IL-4. Cytokine analysis showed that the RANKL/OPG ratio and TNF-α/IL-1ra ratio decreased in PE-treated calvaria following IL-4 addition for 14 days. IL-4 delivery mitigated PE particle-induced osteolysis through macrophage polarization. Modulation of macrophage polarization is a potential treatment strategy for wear particle induced periprosthetic osteolysis.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23225668      PMCID: PMC4073780          DOI: 10.1002/jbm.a.34486

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  53 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis.

Authors:  P Miossec; J Briolay; J Dechanet; J Wijdenes; H Martinez-Valdez; J Banchereau
Journal:  Arthritis Rheum       Date:  1992-08

3.  How prevalent are implant wear and osteolysis, and how has the scope of osteolysis changed since 2000?

Authors:  Amanda Marshall; Michael D Ries; Wayne Paprosky
Journal:  J Am Acad Orthop Surg       Date:  2008       Impact factor: 3.020

Review 4.  Alternative macrophage activation in periprosthetic osteolysis.

Authors:  P Edward Purdue
Journal:  Autoimmunity       Date:  2008-04       Impact factor: 2.815

5.  Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles.

Authors:  Donatella Granchi; Ilaria Amato; Luca Battistelli; Gabriela Ciapetti; Stefania Pagani; Sofia Avnet; Nicola Baldini; Armando Giunti
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479

6.  The epidemiology of bearing surface usage in total hip arthroplasty in the United States.

Authors:  Kevin J Bozic; Steven Kurtz; Edmund Lau; Kevin Ong; Vanessa Chiu; Thomas P Vail; Harry E Rubash; Daniel J Berry
Journal:  J Bone Joint Surg Am       Date:  2009-07       Impact factor: 5.284

7.  Expression profiling reveals alternative macrophage activation and impaired osteogenesis in periprosthetic osteolysis.

Authors:  Panagiotis Koulouvaris; Khanh Ly; Lionel B Ivashkiv; Mathias P Bostrom; Bryan J Nestor; Thomas P Sculco; P Edward Purdue
Journal:  J Orthop Res       Date:  2008-01       Impact factor: 3.494

8.  Derivation and characterization of murine alternatively activated (M2) macrophages.

Authors:  Victor W H Ho; Laura M Sly
Journal:  Methods Mol Biol       Date:  2009

9.  Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma.

Authors:  Trine O Jensen; Henrik Schmidt; Holger Jon Møller; Morten Høyer; Maciej Bogdan Maniecki; Pia Sjoegren; Ib Jarle Christensen; Torben Steiniche
Journal:  J Clin Oncol       Date:  2009-06-15       Impact factor: 44.544

10.  Interleukin-4 inhibition of osteoclast differentiation is stronger than that of interleukin-13 and they are equivalent for induction of osteoprotegerin production from osteoblasts.

Authors:  Atsushi Yamada; Masamichi Takami; Tadaharu Kawawa; Rika Yasuhara; Baohong Zhao; Ayako Mochizuki; Yoichi Miyamoto; Tomoo Eto; Hisataka Yasuda; Yuko Nakamichi; Nacksung Kim; Takenobu Katagiri; Tatsuo Suda; Ryutaro Kamijo
Journal:  Immunology       Date:  2007-04       Impact factor: 7.397

View more
  33 in total

1.  Local delivery of mutant CCL2 protein-reduced orthopaedic implant wear particle-induced osteolysis and inflammation in vivo.

Authors:  Xinyi Jiang; Taishi Sato; Zhenyu Yao; Michael Keeney; Jukka Pajarinen; Tzu-Hua Lin; Florence Loi; Kensuke Egashira; Stuart Goodman; Fan Yang
Journal:  J Orthop Res       Date:  2015-07-29       Impact factor: 3.494

2.  Establishment of NF-κB sensing and interleukin-4 secreting mesenchymal stromal cells as an "on-demand" drug delivery system to modulate inflammation.

Authors:  Tzuhua Lin; Jukka Pajarinen; Akira Nabeshima; Laura Lu; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  Cytotherapy       Date:  2017-07-21       Impact factor: 5.414

3.  Macrophage polarization in response to wear particles in vitro.

Authors:  Joseph K Antonios; Zhenyu Yao; Chenguang Li; Allison J Rao; Stuart B Goodman
Journal:  Cell Mol Immunol       Date:  2013-09-09       Impact factor: 11.530

Review 4.  Are biologic treatments a potential approach to wear- and corrosion-related problems?

Authors:  R Lane Smith; Edward M Schwarz
Journal:  Clin Orthop Relat Res       Date:  2014-12       Impact factor: 4.176

Review 5.  Contributions of human tissue analysis to understanding the mechanisms of loosening and osteolysis in total hip replacement.

Authors:  Jiri Gallo; Jana Vaculova; Stuart B Goodman; Yrjö T Konttinen; Jacob P Thyssen
Journal:  Acta Biomater       Date:  2014-02-10       Impact factor: 8.947

Review 6.  Immunobiology of periprosthetic inflammation and pain following ultra-high-molecular-weight-polyethylene wear debris in the lumbar spine.

Authors:  John H Werner; John H Rosenberg; Kristen L Keeley; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2018-08-21       Impact factor: 4.473

7.  Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells.

Authors:  Eri Katsuyama; Hiroya Miyamoto; Tami Kobayashi; Yuiko Sato; Wu Hao; Hiroya Kanagawa; Atsuhiro Fujie; Toshimi Tando; Ryuichi Watanabe; Mayu Morita; Kana Miyamoto; Yasuo Niki; Hideo Morioka; Morio Matsumoto; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

8.  Innate immune reactions in septic and aseptic osteolysis around hip implants.

Authors:  Jukka Pajarinen; Eemeli Jamsen; Yrjo T Konttinen; Stuart B Goodman
Journal:  J Long Term Eff Med Implants       Date:  2014

9.  Exposure of polyethylene particles induces interferon-γ expression in a natural killer T lymphocyte and dendritic cell coculture system in vitro: a preliminary study.

Authors:  Tzu-Hua Lin; Sunny Kao; Taishi Sato; Jukka Pajarinen; Ruth Zhang; Florence Loi; Stuart B Goodman; Zhenyu Yao
Journal:  J Biomed Mater Res A       Date:  2014-03-19       Impact factor: 4.396

10.  Macromolecular prodrug of dexamethasone prevents particle-induced peri-implant osteolysis with reduced systemic side effects.

Authors:  Ke Ren; Anand Dusad; Fang Yuan; Hongjiang Yuan; P Edward Purdue; Edward V Fehringer; Kevin L Garvin; Steven R Goldring; Dong Wang
Journal:  J Control Release       Date:  2013-12-08       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.